| Title: |
European Glaucoma Society - A guide on surgical innovation for glaucoma |
| Authors: |
Pinto, LA; Mégevand, GS; Stalmans, I; Abouzeid, H; Anastasopoulos, E; Blanco, AA; Bagnasco, L; Bagnis, A; Breda, JB; Barton, K; Bicket, A; Bonnar, J; Bonzano, C; Bourne, R; Bron, A; Bunce, C; Cutolo, C; Cvenkel, B; Fea, A; Filippopoulos, T; Founti, P; Gandolfi, S; Feijoo, JG; Garhoefer, G; Heath, DG; Gazzard, G; Georgoulas, S; Giannoulis, D; Grehn, F; Hu, K; Iester, M; Jayaram, H; Johannesson, G; Kandarakis, S; Karmiris, E; Kastner, A; Katsanos, A; Keskini, C; Khawaja, A; King, A; Kirwan, J; Kolko, M; Koshy, S; Labbe, A; Le, J; Leinonen, S; Lemmens, S; Li, T; Marchini, G; De La Casa, JM; McNaught, A; Gibbons, FM; Mercieca, K; Michelessi, M; Miglior, S; Nikita, E; Oddone, F; Otarola, F; Pazos, M; Pfeiffer, N; Prokosh, V; Qureshi, R; Ratnarajan, G; Reitsamer, H; Rossetti, L; Saldanha, I; Schweitzer, C; Scott, A; Scotto, R; Shah, A; Spaeth, G; Stead, R; Stringa, F; Sunaric, G; Tatham, A; Toeteberg, M; Topouzis, F; Toth, M; Traverso, C; Tuulonen, A; Vass, C; Viswanathan, A; Wormald, R |
| Source: |
British Journal of Ophthalmology , 107 (Suppl 1) pp. 1-114. (2024) |
| Publisher Information: |
BMJ |
| Publication Year: |
2024 |
| Collection: |
University College London: UCL Discovery |
| Subject Terms: |
Humans; Europe; France; Glaucoma; Greece; London |
| Description: |
Prologue Glaucoma surgery has been, for many decades now, dominated by the universal gold standard which is trabeculectomy augmented with antimetabolites. Tubes also came into the scene to complement what we use to call conventional or traditional glaucoma surgery. More recently we experienced a changing glaucoma surgery environment with the "advent"of what we have become used to calling Minimally Invasive Glaucoma Surgery (MIGS). What is the unmet need, what is the gap that these newcomers aim to fill? Hippocrates taught us "bring benefit, not harm"and new glaucoma techniques and devices aim to provide safer surgery compared to conventional surgery. For the patient, but also for the clinician, safety is important. Is more safety achieved with new glaucoma surgery and, if so, is it associated with better, equivalent, or worse efficacy? Is new glaucoma surgery intended to replace conventional surgery or to complement it as an € add-on' to what clinicians already have in their hands to manage glaucoma? Which surgery should be chosen for which patient? What are the options? Are they equivalent? These are too many questions for the clinician! What are the answers to the questions? What is the evidence to support answers? Do we need more evidence and how can we produce high-quality evidence? This EGS Guide explores the changing and challenging glaucoma surgery environment aiming to provide answers to these questions. The EGS uses four words to highlight a continuum: Innovation, Education, Communication, and Implementation. Translating innovation to successful implementation is crucially important and requires high-quality evidence to ensure steps forward to a positive impact on health care when it comes to implementation. The vision of EGS is to provide the best possible well-being and minimal glaucomainduced visual disability in individuals with glaucoma within an affordable healthcare system. In this regard, assessing the changes in glaucoma surgery is a pivotal contribution to better care. As mentioned, this Guide ... |
| Document Type: |
article in journal/newspaper |
| File Description: |
text |
| Language: |
English |
| Relation: |
https://discovery.ucl.ac.uk/id/eprint/10202836/1/EGS%20Guidelines%20on%20Surgical%20Innovation2023.pdf; https://discovery.ucl.ac.uk/id/eprint/10202836/ |
| Availability: |
https://discovery.ucl.ac.uk/id/eprint/10202836/1/EGS%20Guidelines%20on%20Surgical%20Innovation2023.pdf; https://discovery.ucl.ac.uk/id/eprint/10202836/ |
| Rights: |
open |
| Accession Number: |
edsbas.75417965 |
| Database: |
BASE |